CHARLOTTESVILLE, Va., March 01, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical…
Open-label exposure trial expected to initiate in Q2’24 with NDA filing anticipated in 1H 2025SEATTLE and VANCOUVER, British Columbia, Feb.…
— Record revenues of $675 million in 2023 — — Full-year GAAP net income of $42 million and adjusted EBITDA…
$60 million financing upfront with up to an additional $64.2 million tied to exercise of milestone-driven warrants Upfront net proceeds…
AWRS Actively Pursuing In-Network Commercial Insurance CoverageBRENTWOOD, TN / ACCESSWIRE / February 27, 2024 / Another Way Recovery Services Inc.,…
Innovative Treatment Protocol Aims to Revolutionize Fentanyl TreatmentMIAMI, Feb. 27, 2024 (GLOBE NEWSWIRE) -- For those struggling with fentanyl addiction,…
NEW YORK, NY / ACCESSWIRE / February 21, 2024 / Millions of Americans live with schizophrenia, a complex and long…
Toronto, Ontario--(Newsfile Corp. - February 21, 2024) - Safe Supply Streaming Co. Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe…
TAMPA, FL / ACCESSWIRE / February 21, 2024 / In Black Book Research's annual client experience performance ratings for enterprise…
ORLANDO, FL / ACCESSWIRE / February 21, 2024 / SkywardRx, an innovative digital healthcare consulting company, today announced it has…